Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125730611 | 12573061 | 1 | I | 20160714 | 20160720 | 20160720 | PER | US-BIOGEN-2016BI00266951 | BIOGEN | 0.00 | F | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125730611 | 12573061 | 1 | PS | TECFIDERA | DIMETHYL FUMARATE | 1 | Unknown | U | 204063 | UNKNOWN | |||||||||
| 125730611 | 12573061 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | U | 103628 | UNKNOWN | |||||||||
| 125730611 | 12573061 | 3 | SS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | 125104 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125730611 | 12573061 | 1 | Multiple sclerosis |
| 125730611 | 12573061 | 2 | Multiple sclerosis |
| 125730611 | 12573061 | 3 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125730611 | 12573061 | Cognitive disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125730611 | 12573061 | 2 | 20130319 | 0 | ||
| 125730611 | 12573061 | 3 | 20140708 | 0 |